-transparent.png){kind=logo}
The tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) induces release of arachidonic acid (AA) from HeLa cells with a maximum at 2-3 h. Subsequently the extracellular level of AA decreases. Cycloheximide (CH, 10(-5) M does not influence the release of AA, however, it causes the AA level to remain elevated. In the presence of TPA and CH (i) re-uptake of AA is not altered, (ii) re-incorporation of AA into phosphatidylinositol (and phosphatidylethanolamine) is largely increased, and (iii) the level of lysophosphatidylinositol is elevated. The latter two phenomena can be prevented by fluocinolone acetonide (10(-8) M), i.e. by inhibition of phospholipase A2 (PLA2). These data point to a continuously elevated PLA2 activity in the presence of TPA and CH. The phorbol ester appears to induce a proteinaceous principle which diminishes PLA2 activity.
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
October 1993,
The Journal of investigative dermatology,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
November 1990,
Carcinogenesis,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
July 1985,
Biochemical and biophysical research communications,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
February 1995,
Biochimica et biophysica acta,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
February 1984,
Methods and findings in experimental and clinical pharmacology,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
January 1981,
Cancer letters,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
November 1986,
Biochemical and biophysical research communications,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
April 1989,
Biochemical and biophysical research communications,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
April 1986,
Acta physiologica Scandinavica,
M Kaszkin, and
U Espe, and
G Fürstenberger, and
V Kinzel
January 1985,
Journal of neurochemistry,
